Myeloperoxidase-catalyzed 3-chlorotyrosine formation in dialysis patients

Free Radical Biology and Medicine

Volumn 31, Issue 10, 2001, Pages 1163-1169

  Himmelfarb, Jonathan ^a   McMenamin, M Elizabeth ^a,b   Loseto, Gena ^c   Heinecke, Jay W ^c  

^a MAINE MEDICAL CENTER   (United States)

^b Maine Medical Center Research Institute   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Dialysis; Free radicals; Hypochlorous acid; Myeloperoxidase; Oxidation; Phagocyte; Renal failure

Indexed keywords

BIOLOGICAL MARKER; CD11B ANTIGEN; CD18 ANTIGEN; CHLORIDE; COMPLEMENT; HYDROGEN PEROXIDE; HYPOCHLOROUS ACID; MYELOPEROXIDASE; OXIDIZING AGENT; PLASMA PROTEIN; TYROSINE; TYROSINE DERIVATIVE;

ADULT; AGED; AMINO ACID BLOOD LEVEL; ANTIGEN EXPRESSION; ARTICLE; CATALYSIS; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME MECHANISM; FEMALE; GAS CHROMATOGRAPHY; HEMODIALYSIS; HUMAN; ISOTOPE DILUTION ASSAY; LEUKOCYTE ACTIVATION; LONG TERM CARE; MALE; MASS SPECTROMETRY; NEUTROPHIL; OXIDATION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ADULT; AGED; BLOOD PROTEINS; FEMALE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; KIDNEY FAILURE; LEUKOCYTES; MALE; MIDDLE AGED; OXIDATIVE STRESS; PEROXIDASE; PHAGOCYTES; RENAL DIALYSIS; TYROSINE;

EID: 0035890123     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5849(01)00697-9     Document Type: Article

References (49)

1. Oxidative stress in haemodialysis
2. Detection of oxidants in uremic plasma by electron spin resonance spectroscopy
3. Advanced oxidation protein products as a novel marker of oxidative stress in uremia
4. A study of plasmalogen as an index of oxidative stress in patients with chronic renal failure: Evidence of increased oxidative stress in malnourished patients
5. Oxidative stress during dialysis: Effect on free radical scavenging enzyme (FRSE) activities and glutathione (GSH) concentration in granulocytes
6. Oxidative stress in chronic renal failure
7. Physiopathology of the oxidative stress and its implications in uremia and dialysis
8. An overview of haemodialysis and oxidative stress
9. Chronic induction of C-reactive protein by hemodialysis, but not by peritoneal dialysis therapy
10. Determinants of albumin concentration in hemodialysis patients
11. Albumin synthesis, catabolism and distribution in dialysis patients
12. Serum C-reactive protein as a marker for infection and inflammation in regular dialysis patients
13. Factors predicting malnutrition in hemodialysis patients: A cross-sectional study
14. C-reactive protein as an outcome predictor for maintenance hemodialysis patients
15. Acute-phase response predicts erythropoietin resistance in hemodialysis
16. Biological basis of hypoalbuminemia in ESRD
17. Inflammation enhances cardiovascular risk and mortality in hemodialysis patients
18. Association of morbidity with markers of nutrition and inflammation in chronic hemodialysis patients: A prospective study
19. Lipoprotein(a) is a predictor for cardiovascular mortality of hemodialysis patients
20. Role of hypoalbuminemia in the genesis of cardiovascular disease in dialysis patients
21. Reassessing the cardiac risk profile in chronic hemodialysis patients: A hypothesis on the role of oxidant stress and other non-traditional cardiac risk factors
22. Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): Randomised placebo-controlled trial
23. Phagocytic cell function as an index of biocompatibility
24. Polymorphonuclear leukocyte oxidative burst is enhanced in patients with chronic renal insufficiency
25. Plasma levels of main granulocyte components during hemodialysis: Comparison of new and reused dialyzers
26. The effects of dialyzer reuse on plasma antioxidative mechanisms in patients on regular hemodialysis treatment
27. Increase in resting levels of superoxide anion in the whole blood of uremic patients on chronic hemodialysis
28. Biocompatibility of dialysis membranes
29. Protein oxidation and aging
30. Oxidants, antioxidants and the degenerative diseases of aging
31. The role of oxidized lipoproteins in atherogenesis
32. Leukocytic oxygen activation and microbicidal oxidative toxins
33. NADPH oxidase
34. Studies on the chlorinating activity of myeloperoxidase
35. Mechanisms of oxidative damage by myeloperoxidase in atherosclerosis and other inflammatory disorders
36. Mass spectrometric quantification of amino acid oxidation products in protein: Insights into pathways that promote L. D. L.; oxidation in the human artery wall
37. Chlorination of tyrosyl residues in peptides by myeloperoxidase and human neutrophils
38. Human neutrophils employ chlorine gas as an oxidant during phagocytosis
39. 3-Chlorotyrosine, a specific marker of myeloperoxidase-catalyzed oxidation, is markedly elevated in low density lipoprotein isolated from human atherosclerotic intima
40. Detecting oxidative modification of biomolecules with isotope dilution mass spectrometry: Sensitive and quantitative assays for oxidized amino acids in proteins and tissues
41. Superoxide-mediated modification of low density lipoprotein by arterial smooth muscle cells
42. Detection of granulocyte reactive oxygen species production in whole blood using flow cytometry
43. Modulation of granulocyte LAM-1 and MAC-1 during dialysis - A prospective, randomized, controlled trial
44. Mass spectrometric quantification of 3-chlorotyrosine in human tissues with attomole sensitivity: A sensitive and specific marker for myeloperoxidase-catalyzed chlorination at sites of inflammation
45. Bromating oxidants generated by human eosinophils
46. Plasma protein thiol oxidation and carbonyl formation in chronic renal failure
47. Molecular chlorine generated by the myeloperoxidase-hydrogen peroxide-chloride system of phagocytes produces 5-chlorotyrosine in bacterial RNA
48. Neutrophils convert tyrosyl residues in albumin to chlorotyrosine